跳至主要内容
临床试验/EUCTR2005-003854-80-DE
EUCTR2005-003854-80-DE进行中(未招募)不适用

Modulation of the Surgical Inflammatory Response by Etoricoxib: Peripheral versus Central

Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-University0 个研究点开始时间: 2006年1月4日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Subject undergoing elective primary single hip arthroplasty
  • Subject diagnosed with Osteoarthritis / arthrosis
  • Age 55 - 80
  • Subject has not taken non-steroidal anti-inflammatory drugs within 4 of their half life times prior to enrollment
  • Subject capable of understanding and cooperating with the requirements of the study
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients with renal insufficiency (serum creatinine >1.5 mg/dl)
  • Recent major trauma or systemic infection (within 3 months)
  • Use of corticosteroid medication or chronic opioids (within 3 months)
  • Any other condition likely to affect prostaglandin and cytokine levels
  • Participation in another clinical study or receipt of an investigational drug within 30 days
  • Hypersensitivity to any component of the etoricoxib and/or placebo tablets
  • Uncontrolled hypertension defined as systolic blood pressure >160 mm Hg and diastolic pressure >90 mm Hg at rest after two repeated measurements
  • Congestive heart failure (NYHA II-IV)
  • Cerebrovascular disease
  • Established ischemic heart disease (including patients who have recently undergone coronary artery bypass graft surgery or angioplasty)
  • Patients with any kind or severity of cirrhosis of the liver or cholestasis or elevated liver function enzymes (ALT or AST 3 fold) as a sign of clinical significant liver malfunction (corresponds to any Child-Pugh-Score =5)
  • Patients who have developed signs of asthma, acute rhinitis, nasal polyps, angioneurotic oedema or urticaria following the administration of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs)
  • Pregnancy and lactation
  • Patients with active peptic ulcerations or active gastro-intestinal (GI) bleeding,
  • Inflammatory bowel disease
  • Recent history (within the last year) of alcohol or other substance abuse
  • An employee of the sponsor or study site
  • Any neurological syndrome or any other condition leading to contra-indication to spinal anesthesia

研究者

发起方
Department of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-University

相似试验

Modulation of the Surgical Inflammatory Response by... | 临床试验